Globus Medial completed its acquisition of Nevero, a spinal cord stimulator company, according to an April 3 news release.

Per a research report, the global spinal implants and devices market was valued at $13.3 billion in 2023 and is expected to witness a compound annual rate of 5.4% through 2030.

Globus Medical, Inc. GMED continues to benefit from ... and unique surgical instruments used in an expansive range of spinal, orthopedic and neurosurgical procedures. Over the past few quarters ...

Globus Medical, Inc. has announced the commercial ... Porous PEEK™ interbody spacer specifically designed for anterior lumbar interbody fusion, featuring technology that promotes bone in-growth ...

In the assessment of 12-month price targets, analysts unveil insights for Globus Medical, presenting an average target of $90 ...

Globus Medical (NYSE:GMED) announced today that that it completed its previously announced acquisition of Nevro.

Globus Medical GMED recently launched the COHERE ALIF Spacer, the first Porous PEEK interbody spacer for anterior lumbar interbody fusion (ALIF) surgery. Additionally, the company introduced ...

In the preceding three months, 5 analysts have released ratings for Globus Medical ... which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling ...

Globus Medical GMED recently launched the COHERE ALIF Spacer, the first Porous PEEK interbody spacer for anterior lumbar interbody fusion (ALIF) surgery. Additionally, the company introduced Modulus ...

The acquisition of Nevro further expands Globus Medical's presence in the musculoskeletal market, unlocking a $2.5 billion market opportunity. This strategic move positions Globus to further add to ...

AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed ...